COL6A3 and obesity disorder: Here, by integrated two-step proteome-wide MR, colocalization, observational assessments, epigenomics and single-cell RNA sequencing, we identify five mediators of the effects of obesity on cardiometabolic diseases and prioritize COL6A3 as a potentially actionable therapeutic target.